CEO and Chairman Chad M Robins Sells Adaptive Biotechnologies Corp Stock

On April 6 and April 8, 2026, CEO and Chairman Chad M Robins executed sales of Adaptive Biotechnologies Corp common stock. The sales were conducted under a Rule 10b5-1 trading plan adopted on August 11, 2025. On April 6, 83,332 shares were sold at a weighted average price of $14.41, with individual sale prices ranging from $14.19 to $14.84. Following this transaction, Mr. Robins directly owned 2,217,781 shares. On April 8, an additional 37,263 shares were sold at a weighted average price of $15.19, with prices ranging from $15.00 to $15.53. This brought the total directly owned shares to 2,180,518.